- Pediatr Pulmonol. 2009 Oct 12. [Epub ahead of print]
Nocturnal hypoxia and sleep disturbances in cystic fibrosis.
Universidade Federal do Ceara, Fortaleza, CearĂ¡, Brazil.
Disrupted sleep and nocturnal hypoxia are common in cystic fibrosis (CF). However, the predictors of nocturnal hypoxia in CF are still controversial. In order to identify the risk factors for nocturnal desaturation and sleep disturbances, we carried out a clinical and polysomnographic investigation of CF patients.- We studied 30 clinically stable CF cases with clinical lung disease (mean age = 12.8; mean FEV1 = 65.2), 10 CF cases without significant lung disease (mean age = 13.3; mean FEV1 = 99.8), and 20 controls (mean age = 15.5). Patients were evaluated by spirometry, 6-min walk test, the Shwachman-Kulczycki (S-K) score, and full overnight polysomnography. Cases with clinical lung disease had lower body mass index, forced vital capacity, and S-K scores.
- During sleep, five CF cases with clinical lung disease (15%) had SaO(2) <90% p =" 0.02)." sensitivity =" 92.3%;" specificity =" 77.3%)" sensitivity =" 81.8%;" specificity =" 85.2%).">
- requency of impaired sleep was not different in CF cases with (N = 2) and without significant lung disease (N = 5, P = 0.53). Sleep architecture was not significantly different between the two groups. Sleep apnea was present in three CF cases with clinical lung disease and in one case without significant lung disease.
- In summary, desaturation during sleep can be predicted by FEV1 <64%>. There are no significant differences in sleep architecture between clinically stable CF cases with and without significant lung disease. Pediatr Pulmonol. (c)2009 Wiley-Liss, Inc.
PMID: 19824056 [PubMed - as supplied by publisher]
We are here to extend our lives by THINKING DIFFERENT
Sunday, October 18, 2009
Desaturation during sleep can be predicted by FEV1 <64%
Desaturation during sleep can be predicted by FEV1 <64%
Subscribe to:
Post Comments (Atom)
Hmm.
ReplyDeleteTheir summary: "In summary, desaturation during sleep can be predicted by FEV1 <64%>. There are no significant differences in sleep architecture between clinically stable CF cases with and without significant lung disease."
This summary sounds contradictory doesn't it? What is "sleep architecture"? This seems to cancel itself out. What am I missing?
De-satting is very different than sleep architecture.
ReplyDeleteDifferent sleep stages along with REM sleep encompass sleep architecture and correlate with how the body restores itself with sleep.
This isn't the same as your O2 sats at night.